Re: [新闻] 杏国 本公司研发中新药SB05PC全球胰脏癌

楼主: galaxiehuang (misterdonut来看^_^思,1)   2020-07-30 22:02:50
大家可以用
Gemcitabine after Folfirinox 去找已经做过的实验
杏国的药是SB05PC + Gemcitabine 跟 Gemcitabine 单药比.
以我任取一篇的结论来看
https://reurl.cc/Qd05GZ
Folfirinox失败后用Gemcitabine继续治疗
96 patients were included (male, 51%; median age, 62;
performance status (PS) 0-1, 47%).
Median duration on gemcitabine was 2.1 months.
The overall disease control rate was 40%.
Median OS was 3.7 months (95%CI: 2.5-5.2) and
median PFS was 2.1 months (95%CI: 2.0-2.6)
96个病患,平均年纪62岁,
mOS 3.7个月
mPFS 2.1个月
大家可以去找杏国二期实验收进的病人状况(几岁,多少人等)
mOS是 7.3个月, 比上面的实验多了3.6个月
数学好的应该可以根据这些数据稍微算一下期中分析成功的机率,
期末分析成功的机率各是多少?
当然杏国的卖点是将紫衫醇包进去的技术,若胰脏癌成功还可以推广到其他癌症,
所以第一个适应症最重要,也希望他成功啦!

Links booklink

Contact Us: admin [ a t ] ucptt.com